• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KERR CORPORATION OPTIBOND XTR; RESIN TOOTH BONDING AGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KERR CORPORATION OPTIBOND XTR; RESIN TOOTH BONDING AGENT Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Sensitivity of Teeth (2427)
Event Type  Injury  
Event Description
A doctor alleged that one hundred and twenty (120) patients had experienced sensitivity after restorations were placed using the optibond xtr product.This is the fifty-fourth of one hundred and twenty (120) reports.
 
Manufacturer Narrative
Specific patient information with regard to gender, age, and weight was not provided.The doctor reported that the patient had contacted the office within approximately three (3) days of placement reporting sensitivity issues.The doctor had the patient return to the office and took an x-ray; however, no issues with the restoration were noted.The doctor requested that the patient wait 2-3 weeks to see if the sensitivity would subside; however, after waiting the requested time, the sensitivity was still present.The doctor had the patient return to the office and replaced the patient's restorations.No treatment dates were provided.The doctor reported that the sensitivity has been reduced; however, the patient is still experiencing some sensitivity.The optibond xtr product (adhesive (catalog #35108, lot #4674868) and primer (catalog # 35107 and lot #4657224)) involved in the alleged incident was not returned; therefore, a visual evaluation was performed on a retained sample, yielding results within specifications.A dhr review indicated that there were no deviations from the manufacturing process.In addition, no similar complaints were received with regard to this lot.
 
Manufacturer Narrative
It was discovered on (b)(6) 2014 that the doctor had not refrigerated the optibond xtr product, which is required as per the directions for use.It was initially reported that the product involved in the alleged incident was not returned and evaluations were performed on a retained sample; however, the optibond xtr product (adhesive (catalog #35108, lot #4674868 and primer (catalog # 35107 and lot #4657224)) involved in the alleged incident had been returned and the visual evaluation was performed on the returned sample, which yielded results within specifications.A dhr review indicated that there were no deviations from the manufacturing process.In addition, no similar complaints were received with regard to these lots.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIBOND XTR
Type of Device
RESIN TOOTH BONDING AGENT
Manufacturer (Section D)
KERR CORPORATION
1717 west collins avenue
orange CA 92867
Manufacturer (Section G)
KERR CORPORATION
1717 west collins avenue
orange CA 92867
Manufacturer Contact
kerri casino
1717 west collins avenue
orange, CA 92867
7145167634
MDR Report Key3833267
MDR Text Key4503463
Report Number2024312-2014-00352
Device Sequence Number1
Product Code KLE
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K101423
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Dentist
Type of Report Initial,Followup
Report Date 04/16/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/27/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Dentist
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/16/2014
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
(B)(4); SONICFILL
Patient Outcome(s) Other; Required Intervention;
-
-